Synergy Disc® IDE Trial Results to Be Presented at ISASS 2026 by Dr. Todd H. Lanman

The first full U.S. IDE trial results for the FDA-approved Synergy Disc® will be presented at ISASS 2026 by principal investigator Dr. Todd H. Lanman. The data highlights superior outcomes compared to fusion, including improved function, lower pain scores, and higher patient satisfaction.

This milestone reflects continued progress in motion-preserving spine surgery and reinforces the expanding role of artificial disc replacement in modern spine care.